NEW YORK--(BUSINESS WIRE)--Gentium S.p.A. (Nasdaq: GENT) announced the election of Mr. Malcolm Sweeney to the Company’s Board of Directors. Mr. Sweeney was formerly the Head of Financial Reporting and Accounting for the Pharma Division of Novartis, AG. Prior to Novartis Mr. Sweeney worked for IMS Health Inc., (formerly IMS International), a provider of market intelligence to the pharmaceutical and healthcare industries. He held positions of Corporate Controller and Senior Director of Finance for IMS, as well Leader of European Shared Services for Dun and Bradstreet (former owner of IMS). From 1974 to 1990, he held a variety of finance positions for a number of Divisions of General Electric. Mr. Sweeney resides in the U.K., is a chartered accountant, admitted to the Institute of England & Wales in 1974 when working for KPMG (formerly Peat, Marwick, Mitchell and Co.). He received a Bachelor of Science in Physics, Economics and Philosophy from the University of Exeter in 1970.
